Fri, Sep 19, 2014, 5:56 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • muppettsalad muppettsalad Jan 6, 2013 1:02 PM Flag

    Hey Darko Demento what does this mean?

    Re: Re: Re: ISIS trials for Kynamro have been ongoing, why would FDA not halt them ?
    by barristerbs . Jan 6, 2013 11:23 AM . Permalink
    PSLRA did heighten Sanctions for strike complaints. It would be interesting to see ISIS, upon receipt of FDA approval, go for counter claims of say 200 billion. Why so high? They have hundreds of diseases to tackle. They cannot afford 200,000 class action complaints slanted at and gambled upon each (potential) rejection for a license. All the FDA panel did was to suggest measures in the ongoing license, if granted, to be sure heart attacks, liver failure and cancer are not caused by Kynamro because there is no way to rule it out at this time, with 130 patients under study. That was the panel's opinion and I am not sure if its certain individuals or the whole panel's authority and opinion. Readers need to remember, severe FH patients die at the rate of 50% by age 50. The panel could just as well concluded ISIS saved some 20 people from certain death, only, as with the negative outcomes, the positive are also too soon to tell with so little statistical data.
    Sentiment: Strong Buy
    0users liked this posts0users disliked this posts
    Reply
    Re: Re: Re: Re: ISIS trials for Kynamro have been ongoing, why would FDA not halt them ?
    by barristerbs . Jan 6, 2013 11:24 AM . Permalink
    and remember, the reported statistical EFFICACY data WAS NOT CHALLENGED by the panel and they voted to APPROVE A LICENSE. Contrary to and exposing Dark's demented view.
    Sentiment: Strong Buy

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ISIS
42.28+0.40(+0.96%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.